| Catalog Number |
115-253 |
| Medical Device Problem Code |
Material Rupture (1546)
|
| Health Effect - Clinical Code |
Seroma (2069)
|
| Date of Event |
10/21/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Healthcare professional reported via customer portal left side rupture, double capsule, seroma, "scattered papillary growth", "breast enlargement / pain", and "textured".Device has been explanted.
|
| |
|
Additional Manufacturer Narrative
|
|
Visual analysis of the photographs identified: ¿ rupture: observed but cannot perform an assessment of the opening as no microscopic analysis can be performed.¿ pain: unable to observe since it is not related to the device.¿ seroma: unable to observe since it is not related to the device.¿ double capsule: unable to observe since it is not related to the device.¿ visibility/palpability: unable to observe since it is not related to the device.¿ anxiety-product/ procedure: unable to observe since it is not related to the device.No additional observations are performed.No further actions are required as no manufacturing issues are observed.
|
| |
|
Additional Manufacturer Narrative
|
|
A review of the device history record has been completed.No deviations or non-conformances noted.The event of "seroma-late" is a physiological complication.And analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: device rupture and seroma-late.
|
| |
|
Event or Problem Description
|
|
Healthcare professional reported, via customer portal left side rupture.Double capsule, seroma, "scattered papillary growth", "breast enlargement/pain" and "textured".Device has been explanted.
|
| |
|
Event or Problem Description
|
|
Healthcare professional reported via customer portal left side rupture, double capsule, seroma, "scattered papillary growth", "breast enlargement / pain", and "textured".Device has been explanted.
|
| |
|
Additional Manufacturer Narrative
|
|
Device evaluation: based on the product analysis performed, the assessments of the complaint codes are: ¿ visibility/palpability: unable to observe as it is not related to the manufacturing process.¿seroma: unable to observe as it is not related to the manufacturing process.¿rupture: observed an opening assessed as fold flaw opening ¿pain: unable to observe as it is not related to the manufacturing process.¿double capsule: unable to observe as it is not related to the manufacturing process.¿anxiety - product/ procedure: unable to observe as it is not related to the manufacturing process.As per the investigation procedure, crease/wear abrasion were observed and none of the observations are found to be potentially related to the manufacturing process, no further actions are required.
|
| |
|
Search Alerts/Recalls
|